
Robert Beall, president of the Bethesda-based Cystic Fibrosis Foundation, led the group’s decision in the late 1990s to invest in a small California biotechnology firm. (Amanda Voisard for The Washington Post)

Robert Beall, president of the Bethesda-based Cystic Fibrosis Foundation, led the group’s decision in the late 1990s to invest in a small California biotechnology firm. (Amanda Voisard for The Washington Post)